Literature DB >> 17488639

Integrative metabolic regulation of peripheral tissue fatty acid oxidation by the SRC kinase family member Fyn.

Claire C Bastie1, Haihong Zong, Jun Xu, Bhavin Busa, Stefan Judex, Irwin J Kurland, Jeffrey E Pessin.   

Abstract

Mice null for Fyn (a member of the Src family of nonreceptor tyrosine kinases) display a reduced percentage of adipose mass associated with decreased adipocyte cell size. In parallel, there is a substantial reduction in fasting plasma glucose, insulin, triglycerides, and free fatty acids concomitant with decreased intrahepatocellular and intramyocellular lipid accumulation. Importantly, the Fyn null mice exhibit improved glucose tolerance resulting from increased peripheral tissue (adipose and skeletal muscle) insulin sensitivity with a very small effect in the liver. Moreover, whole-body, adipose, and skeletal muscle fatty acid uptake and oxidation are increased along with AMP kinase activation and acetyl-CoA carboxylase inhibition. Together, these data demonstrate crosstalk between Src-family kinase activity and fatty acid oxidation and show that the loss of Fyn markedly improves peripheral tissue insulin sensitivity by relieving a selective negative modulation of AMP kinase activity in adipose tissue and skeletal muscle.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17488639     DOI: 10.1016/j.cmet.2007.04.005

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  44 in total

1.  What we have learnt about PIKE from the knockout mice.

Authors:  Chi Bun Chan; Keqiang Ye
Journal:  Int J Biochem Mol Biol       Date:  2011-06-07

2.  Mechanically activated Fyn utilizes mTORC2 to regulate RhoA and adipogenesis in mesenchymal stem cells.

Authors:  William R Thompson; Christophe Guilluy; Zhihui Xie; Buer Sen; Kaitlyn E Brobst; Sherwin S Yen; Gunes Uzer; Maya Styner; Natasha Case; Keith Burridge; Janet Rubin
Journal:  Stem Cells       Date:  2013-11       Impact factor: 6.277

3.  Fyn-phosphorylated PIKE-A binds and inhibits AMPK signaling, blocking its tumor suppressive activity.

Authors:  S Zhang; Q Qi; C B Chan; W Zhou; J Chen; H R Luo; C Appin; D J Brat; K Ye
Journal:  Cell Death Differ       Date:  2015-05-22       Impact factor: 15.828

4.  Fyn regulates adipogenesis by promoting PIKE-A/STAT5a interaction.

Authors:  Margaret Chui Ling Tse; Xia Liu; Seran Yang; Keqiang Ye; Chi Bun Chan
Journal:  Mol Cell Biol       Date:  2013-02-25       Impact factor: 4.272

5.  Fyn kinase regulates translation in mammalian mitochondria.

Authors:  Emine C Koc; Jennifer L Miller-Lee; Hasan Koc
Journal:  Biochim Biophys Acta Gen Subj       Date:  2016-12-07       Impact factor: 3.770

6.  Adipogenesis is inhibited by brief, daily exposure to high-frequency, extremely low-magnitude mechanical signals.

Authors:  C T Rubin; E Capilla; Y K Luu; B Busa; H Crawford; D J Nolan; V Mittal; C J Rosen; J E Pessin; S Judex
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-24       Impact factor: 11.205

7.  A concerted kinase interplay identifies PPARgamma as a molecular target of ghrelin signaling in macrophages.

Authors:  Annie Demers; Véronique Caron; Amélie Rodrigue-Way; Walter Wahli; Huy Ong; André Tremblay
Journal:  PLoS One       Date:  2009-11-04       Impact factor: 3.240

8.  Beta-arrestin inhibits CAMKKbeta-dependent AMPK activation downstream of protease-activated-receptor-2.

Authors:  Ping Wang; Yong Jiang; Yinsheng Wang; John Y Shyy; Kathryn A DeFea
Journal:  BMC Biochem       Date:  2010-09-21       Impact factor: 4.059

9.  Deficiency of phosphoinositide 3-kinase enhancer protects mice from diet-induced obesity and insulin resistance.

Authors:  Chi Bun Chan; Xia Liu; Dae Young Jung; John Y Jun; Hongbo R Luo; Jason K Kim; Keqiang Ye
Journal:  Diabetes       Date:  2010-01-12       Impact factor: 9.461

10.  Sarcoglycan complex: implications for metabolic defects in muscular dystrophies.

Authors:  Séverine Groh; Haihong Zong; Matthew M Goddeeris; Connie S Lebakken; David Venzke; Jeffrey E Pessin; Kevin P Campbell
Journal:  J Biol Chem       Date:  2009-06-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.